Lupin share price
You have to be logged in to add this to Watchlist.- ₹2,168.35(-2.21%)February 6, 2026 15:45:19 PM IST
- NSE
- BSE
- Vol : 653.59 K (NSE + BSE)Last 20 day avg : 879.50 K
Lupin is trading -2.21% lower at Rs 2,168.35 as compared to its last closing price. Lupin has been trading in the price range of 2,210.00 & 2,160.00. Lupin has given 5.17% in this year & 3.05% in the last 5 days. Lupin has TTM P/E ratio 20.17 as compared to the sector P/E of 23.40.There are 36 analysts who have initiated coverage on Lupin. There are 10 analysts who have given it a strong buy rating & 14 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 1,477.92 Crores in its last quarter.Listed peers of Lupin include Torrent Pharmaceuticals (-1.04%), Dr Reddy's Laboratories (-0.29%), Cipla (-0.14%).The Mutual Fund holding in Lupin was at 18.01% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Lupin was at 21.50% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 07, 2026, 08:34 PM UTC
- BetaLow volatility0.72Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.32The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.54Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 3,931.65 | -1.04 | 1,33,059.55 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Neutral | 1,241.60 | -0.29 | 1,03,622.86 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Moderately Bearish | 1,330.80 | -0.14 | 1,07,490.21 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Neutral | 1,694.90 | -0.43 | 4,06,653.70 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | Bearish | 6,027.00 | -1.78 | 1,60,509.28 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
- IndustryBiotechnology & Drugs
- ISININE326A01037
- BSE Code500257
- NSE CodeLUPIN
Lupin is trading at 2168.35 as on Fri Feb 06 2026 10:15:19. This is -2.21% lower as compared to its previous closing price of 2217.40.
The market capitalization of Lupin is 98963.91 Cr as on Fri Feb 06 2026 10:15:19.
The average broker rating on Lupin is Buy. The breakup of analyst rating is given below -
- 10 analysts have given a strong buy rating
- 14 analysts have given a buy rating
- 9 analysts have given a hold rating
- 3 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Lupin is 2249.30 whereas the 52 wk low is 1774.00
Lupin can be analyzed on the following key metrics -
- TTM P/E: 20.17
- Sector P/E: 23.40
- Dividend Yield: 0.54%
- D/E ratio: 0.32
Lupin reported a net profit of 3281.62 Cr in 2025.
The Mutual Fund Shareholding was 18.01% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Lupin QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.